{"release_id":19,"data":{"id":80398,"release_id":19,"source_id":"sg.guidance.hsa-post-marketing-vigilance-v6","kind":"entity","fingerprint":"eff7e8006e51c8647f70d416dd6046cfc72c7d1cf98a7bf0f3d992266cf45fdf","title_en":"HSA Post-marketing Vigilance Guidance Version 6","title_zh":"HSA \u4e0a\u5e02\u540e\u76d1\u6d4b\u6307\u5357\u7b2c 6 \u7248","domain":null,"status":null,"assurance":null,"subtype":"post-marketing-safety-surveillance-guidance","lat":null,"lon":null,"date":null,"payload":{"bundle_sha256":"45bf7e4a6e04877a9385caa9d5613e31f964959fced55c1117ce10170e4f73ce","checks":{"translation":"passed"},"data":{"aliases":["HSA post-marketing vigilance guidance","Version 6 vigilance guidance"],"aliases_i18n":[],"assurance":"curated","class":"scheme","deprecated":false,"entity_type":"post-marketing-safety-surveillance-guidance","established":"2026-04-01","id":"sg.guidance.hsa-post-marketing-vigilance-v6","jurisdiction":"SG","labels":[],"name":"HSA Post-marketing Vigilance Guidance Version 6","parent_id":"sg.agency.hsa","record_type":"entity","redirect_to":null,"source_url":"https:\/\/isomer-user-content.by.gov.sg\/409\/a6db49dc-ed7f-4e44-93ad-7fb906e7d2f8\/Guidance%20for%20Industry_Post-marketing%20Vigilance%20Requirements%20for%20Therapeutic%20Products%20and%20CTGTP_V.pdf","summary":null,"title":"HSA Post-marketing Vigilance Guidance Version 6","type":"post-marketing-safety-surveillance-guidance"},"date":null,"domain":null,"evidence_paths":["artefacts\/knowledge-graph.jsonl","artefacts\/knowledge-records.jsonl"],"kind":"entity","links":[{"relation":"parent_id","target_id":"sg.agency.hsa"},{"relation":"topics","target_id":"sgtopic.healthcare.hsa-post-marketing-vigilance-guidance-2026"}],"source_id":"sg.guidance.hsa-post-marketing-vigilance-v6","status":null,"summary_en":"","summary_zh":"","title_en":"HSA Post-marketing Vigilance Guidance Version 6","title_zh":"HSA \u4e0a\u5e02\u540e\u76d1\u6d4b\u6307\u5357\u7b2c 6 \u7248","translation_work":[{"field":"title_zh","fingerprint":"32dabeb8307d4649512af73d59213a7777195ab9a8285d7f18819c0d3272e5db","source_en":"HSA Post-marketing Vigilance Guidance Version 6","status":"reused"}]},"search_text":"HSA Post-marketing Vigilance Guidance Version 6\nHSA \u4e0a\u5e02\u540e\u76d1\u6d4b\u6307\u5357\u7b2c 6 \u7248\n\n\n{\"aliases\":[\"HSA post-marketing vigilance guidance\",\"Version 6 vigilance guidance\"],\"aliases_i18n\":[],\"assurance\":\"curated\",\"class\":\"scheme\",\"deprecated\":false,\"entity_type\":\"post-marketing-safety-surveillance-guidance\",\"established\":\"2026-04-01\",\"id\":\"sg.guidance.hsa-post-marketing-vigilance-v6\",\"jurisdiction\":\"SG\",\"labels\":[],\"name\":\"HSA Post-marketing Vigilance Guidance Version 6\",\"parent_id\":\"sg.agency.hsa\",\"record_type\":\"entity\",\"redirect_to\":null,\"source_url\":\"https:\\\/\\\/isomer-user-content.by.gov.sg\\\/409\\\/a6db49dc-ed7f-4e44-93ad-7fb906e7d2f8\\\/Guidance%20for%20Industry_Post-marketing%20Vigilance%20Requirements%20for%20Therapeutic%20Products%20and%20CTGTP_V.pdf\",\"summary\":null,\"title\":\"HSA Post-marketing Vigilance Guidance Version 6\",\"type\":\"post-marketing-safety-surveillance-guidance\"}\n"},"related":[{"id":90524,"source_id":"sgkb.healthcare.hsa-post-marketing-vigilance-guidance-2026","kind":"article","title_en":"HSA Post-marketing Vigilance Guidance 2026","title_zh":"HSA \u4e0a\u5e02\u540e\u8b66\u6212\u6307\u5357 2026","assurance":null,"subtype":null},{"id":79809,"source_id":"sg.agency.hsa","kind":"entity","title_en":"Health Sciences Authority","title_zh":"\u536b\u751f\u79d1\u5b66\u5c40","assurance":null,"subtype":"statutory-board"},{"id":92733,"source_id":"sgtopic.healthcare.hsa-post-marketing-vigilance-guidance-2026","kind":"topic","title_en":"HSA Post-marketing Vigilance Guidance 2026","title_zh":"HSA \u4e0a\u5e02\u540e\u76d1\u6d4b\u6307\u5357 2026 \u5e74","assurance":null,"subtype":null}]}